Conferences Rigel Pharmaceuticals is attending in 2026

LinkedIn rigel.com

Rigel Pharmaceuticals is listed at 2 conferences on Tnuki's calendar in 2026: SABCS 2026 (exhibiting) and ASH 2026 (exhibiting). Rigel Pharmaceuticals is a biopharmaceutical company developing medicines for hematologic disorders, cancer, and immune-mediated diseases. As of Sep 29, 2026.

ConferenceDetailsInvolvementTnuki guide
San Antonio Breast Cancer Symposium 2026Breast cancer clinicians & researchersOfficial site
San Antonio, TX ~11k attendees ExhibitorAs published by SABCS (UT Health San Antonio, AACR)
Booth 1311
Attendee mix: Mostly clinical & academic; breast cancer oncologists, translational researchers and oncology biopharma teams
Open the guide Search and filter attendees
ASH 2026 Annual Meeting & ExpositionHematologists & blood cancer researchersOfficial site
New Orleans, LA ~30k attendees ExhibitorAs published by American Society of Hematology
Booth 613Program 2 symposia
Attendee mix: Mostly clinical; hematologists, KOLs, hematologic-oncology researchers, medical affairs and cell-therapy biopharma teams
Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 29 of the 90 conferences on our calendar, so this page shows Rigel Pharmaceuticals’s involvement at those 29 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at Rigel Pharmaceuticals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →